An­oth­er de­pres­sion tri­al goes bust, as Min­er­va drug fails PhII study

De­pres­sion tri­als tend to reap de­press­ing re­sults. On­ly weeks ago, Sage Ther­a­peu­tics’ keen­ly an­tic­i­pat­ed piv­otal tri­al in ma­jor de­pres­sive dis­or­der (MDD)

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.